Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | APEX nuclease (multifunctional DNA repair enzyme) 1 | Starlite/ChEMBL | No references |
Homo sapiens | glutaminase | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | exonuclease III APE | 0.0023 | 0 | 0.5 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.1781 | 1 | 1 |
Onchocerca volvulus | 0.0301 | 0.1582 | 0.5 | |
Echinococcus granulosus | carboxylesterase 5A | 0.1781 | 1 | 1 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.0301 | 0.1582 | 0.9053 |
Loa Loa (eye worm) | hypothetical protein | 0.0301 | 0.1582 | 0.1582 |
Echinococcus granulosus | neuroligin | 0.0301 | 0.1582 | 0.1582 |
Onchocerca volvulus | 0.0301 | 0.1582 | 0.5 | |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0023 | 0 | 0.5 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0301 | 0.1582 | 0.1582 |
Echinococcus multilocularis | acetylcholinesterase | 0.1781 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0301 | 0.1582 | 0.1582 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0301 | 0.1582 | 1 |
Echinococcus granulosus | para nitrobenzyl esterase | 0.0301 | 0.1582 | 0.1582 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.1781 | 1 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.033 | 0.1748 | 0.1748 |
Brugia malayi | glutaminase DH11.1 | 0.033 | 0.1748 | 0.1748 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0053 | 0.0172 | 0.0172 |
Brugia malayi | Carboxylesterase family protein | 0.0301 | 0.1582 | 0.1582 |
Echinococcus multilocularis | BC026374 protein (S09 family) | 0.0301 | 0.1582 | 0.1582 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0023 | 0 | 0.5 |
Loa Loa (eye worm) | glutaminase | 0.033 | 0.1748 | 0.1748 |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.0301 | 0.1582 | 0.9053 |
Loa Loa (eye worm) | carboxylesterase | 0.0301 | 0.1582 | 0.1582 |
Schistosoma mansoni | BC026374 protein (S09 family) | 0.0301 | 0.1582 | 0.1582 |
Loa Loa (eye worm) | hypothetical protein | 0.0301 | 0.1582 | 0.1582 |
Loa Loa (eye worm) | hypothetical protein | 0.1781 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0301 | 0.1582 | 0.1582 |
Echinococcus multilocularis | carboxylesterase 5A | 0.1781 | 1 | 1 |
Trichomonas vaginalis | glutaminase, putative | 0.033 | 0.1748 | 1 |
Onchocerca volvulus | 0.0301 | 0.1582 | 0.5 | |
Brugia malayi | hypothetical protein | 0.0301 | 0.1582 | 0.1582 |
Schistosoma mansoni | acetylcholinesterase | 0.0301 | 0.1582 | 0.1582 |
Loa Loa (eye worm) | hypothetical protein | 0.0301 | 0.1582 | 0.1582 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0053 | 0.0172 | 0.0172 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0939 | 0.5211 | 0.5211 |
Schistosoma mansoni | glutaminase | 0.033 | 0.1748 | 0.1748 |
Onchocerca volvulus | 0.0301 | 0.1582 | 0.5 | |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0301 | 0.1582 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0053 | 0.0172 | 0.0172 |
Loa Loa (eye worm) | carboxylesterase | 0.1781 | 1 | 1 |
Echinococcus multilocularis | acetylcholinesterase | 0.1781 | 1 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0023 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0023 | 0 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0053 | 0.0172 | 0.0172 |
Echinococcus multilocularis | neuroligin | 0.0301 | 0.1582 | 0.1582 |
Echinococcus granulosus | family S9 non peptidase ue S09 family | 0.0301 | 0.1582 | 0.1582 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0023 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0053 | 0.0172 | 0.0172 |
Onchocerca volvulus | 0.0301 | 0.1582 | 0.5 | |
Schistosoma mansoni | gliotactin | 0.0301 | 0.1582 | 0.1582 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0023 | 0 | 0.5 |
Schistosoma mansoni | neuroligin 3 (S09 family) | 0.0301 | 0.1582 | 0.1582 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0053 | 0.0172 | 0.0172 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0023 | 0 | 0.5 |
Brugia malayi | Carboxylesterase family protein | 0.0301 | 0.1582 | 0.1582 |
Brugia malayi | Carboxylesterase family protein | 0.1781 | 1 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.1781 | 1 | 1 |
Echinococcus multilocularis | family S9 non peptidase ue (S09 family) | 0.0301 | 0.1582 | 0.1582 |
Brugia malayi | Carboxylesterase family protein | 0.0301 | 0.1582 | 0.1582 |
Echinococcus granulosus | acetylcholinesterase | 0.1781 | 1 | 1 |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.0301 | 0.1582 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0053 | 0.0172 | 0.0172 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0023 | 0 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0053 | 0.0172 | 0.0172 |
Loa Loa (eye worm) | hypothetical protein | 0.0301 | 0.1582 | 0.1582 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0023 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0301 | 0.1582 | 0.1582 |
Echinococcus multilocularis | para nitrobenzyl esterase | 0.0301 | 0.1582 | 0.1582 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0053 | 0.0172 | 0.0172 |
Loa Loa (eye worm) | hypothetical protein | 0.0301 | 0.1582 | 0.1582 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.0301 | 0.1582 | 0.9053 |
Brugia malayi | Carboxylesterase family protein | 0.0301 | 0.1582 | 0.1582 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0023 | 0 | 0.5 |
Mycobacterium ulcerans | glutaminase | 0.033 | 0.1748 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0301 | 0.1582 | 0.1582 |
Loa Loa (eye worm) | carboxylesterase | 0.0301 | 0.1582 | 0.1582 |
Echinococcus granulosus | BC026374 protein S09 family | 0.0301 | 0.1582 | 0.1582 |
Loa Loa (eye worm) | hypothetical protein | 0.1781 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 6.3096 uM | PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.8876 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 89.1251 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.